Abbott pushes back closure date on Canadian plant

Abbott Laboratories employees at a plant in Ontario, Canada, can breath a sigh of relief--at least for now. The facility, slated for closure, will stay open for another year to 18 months, thanks to a spike in short-term demand for the products made there. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.